Breast Cancer News

The University of Texas MD Anderson Cancer Center has retained its distinction as the No. 1 cancer hospital in the country.

Cancer survivors with the lowest socioeconomic status appeared twice as likely to die of CVD than those with the highest household incomes, according to a study published in European Heart Journal – Quality of Care and Clinical Outcomes.

Elizabeth A. Comen, MD, has been appointed associate professor in the department of medicine at NYU Langone Health’s Perlmutter Cancer Center.

CHICAGO — Most individuals with cancer who used an AI-based nutritional platform reported the application helped them regulate their diets and improved their quality of life, according to study results presented at ASCO Annual Meeting.

Compared with non-Hispanic white individuals, patients from racial and ethnic minority groups experienced similar clinical benefits when participating in phase 1 trials for advanced cancers, data published in JAMA Network Open showed.

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

In this episode, host Shikha Jain, MD, speaks with Komal Jhaveri, MD, about breakthroughs in breast cancer treatment, where the field is evolving with anti-body drug conjugates and more.

Editor’s note: This is the third in a series of five stories from ASCO Voices, a session during ASCO Annual Meeting that focused on the human side of oncology.

CHICAGO — The addition of abemaciclib to fulvestrant extended PFS for patients with advanced breast cancer whose disease progressed on prior cyclin-dependent kinase 4/6 inhibitor therapy, according to data presented at ASCO Annual Meeting.

People with type 2 diabetes who use a GLP-1 receptor agonist have a lower risk for 10 types of obesity-associated cancer compared with those who use insulin, according to data published in JAMA Network Open.